| Literature DB >> 35087650 |
Linli Qi1, Xiaoxia Guo2, Chunyan Nie3, Xin Lv1, Miao Zhang1.
Abstract
Cerebral hemorrhage is a kind of intracranial hemorrhage caused by nontraumatic vascular rupture of the cerebral parenchyma, which is a common cerebrovascular disease with a high disability rate and mortality. This study aimed to explore the effects of oropharyngeal aspiration in reducing ventilator-associated pneumonia in patients with cerebral hemorrhage in ICU. In this study, 96 patients with cerebral hemorrhage were selected as the subjects. They received surgical treatment, and then they were transferred into ICU of Fourth Affiliated Hospital of Harbin Medical University from December 2019 to March 2020. The patients were randomly divided into intervention group and control group, with 48 in each group. The intervention group received periodic oropharyngeal aspiration, while the control group received routine nursing measures. After the intervention, the incidence of ventilator-associated pneumonia and the positive rate of amylase α-trachea cannula specimens were recorded and compared between the two groups. After the intervention, the incidence of ventilator-associated pneumonia was 14.89% in the intervention group and 39.58% in the control group, with a statistically significant difference. And, the α-amylase positive rate, mechanical ventilation time, and ICU care duration of endotrachea cannula specimens in the intervention group were significantly lower than those in the control group. In conclusion, oropharyngeal aspiration can effectively reduce the incidence of ventilator-associated pneumonia after cerebral hemorrhage and shorten mechanical ventilation and ICU care duration. It promotes the rehabilitation of patients.Entities:
Mesh:
Year: 2022 PMID: 35087650 PMCID: PMC8789453 DOI: 10.1155/2022/6433666
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Comparative of incidence of ventilator-associated pneumonia n (%).
| Group | Ventilator pneumonia |
| Chi-square |
| |
|---|---|---|---|---|---|
| Yes | No | ||||
| Intervention group | 7 (14.58) | 41 (85.42) | 48 | 7.596 | 0.006 |
| Control group | 19 (39.58) | 29 (60.42) | 48 | ||
Differences in positive specimen rates between two groups.
| Group | Positive | Negative |
| Chi-square |
|
|---|---|---|---|---|---|
| Intervention group | 22 (45.83) | 26 (54.17) | 48 | 9.895 | 0.002 |
| Control group | 37 (77.08) | 11 (60.42) | 48 |
Difference of α-amylase content in specimens between two groups ( ± SD).
| Intervention group | Control group |
|
| |
|---|---|---|---|---|
|
| 17982 ± 16643 | 10569 ± 11838 | 2.515 | 0.014 |
Differences in levels of validation response indexes after intervention between two groups ( ± SD).
| Inflammatory indexes | Intervention group ( | Control group ( |
|
|
|---|---|---|---|---|
| IL-6 (ng/L) | 247.67 ± 25.93 | 279.36 ± 25.48 | 6.039 | <0.001 |
| IL-8 (pg/ml) | 325.83 ± 32.19 | 350.74 ± 35.72 | 3.589 | 0.001 |
| PSP (ng/ml) | 40.90 ± 8.16 | 49.98 ± 9.63 | 4.984 | <0.001 |
| NE ( | 153.77 ± 34.57 | 207.24 ± 38.37 | 7.713 | <0.001 |
| su-PAR (ng/ml) | 8.21 ± 2.15 | 12.06 ± 2.42 | 8.240 | <0.001 |
| IL-35 (pg/ml) | 30.96 ± 4.77 | 37.78 ± 4.85 | 6.946 | <0.001 |
| sTREM-1 (pg/ml) | 174.13 ± 26.32 | 188.53 ± 29.59 | 2.519 | 0.013 |
| PTX-3 (ng/ml) | 14.25 ± 6.42 | 21.39 ± 8.74 | 4.562 | <0.001 |
| PCT ( | 0.57 ± 0.20 | 0.79 ± 0.26 | 9.833 | <0.001 |
Comparison of mechanical ventilation time and ICU care duration after intervention between two groups ( ± SD).
| Group | Number of cases (cases) | Mechanical ventilation time (Day) | ICU care duration (Day) |
|---|---|---|---|
| Intervention group | 48 | 5.16 ± 1.69 | 7.20 ± 2.65 |
| Control group | 48 | 9.80 ± 1.20 | 10.68 ± 2.92 |
|
| 15.509 | 6.114 | |
|
| 0.000 | 0.000 | |